JUNDISHAPUR JOURNAL OF MICROBIOLOGY, vol.11, no.11, 2018 (SCI-Expanded)
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a leading pathogen of serious infectious diseases in intensive care units. Novel antibiotic combination therapies are needed to treat serious infectious diseases caused by MRSA.